Literature DB >> 15194566

Substance P and neutral endopeptidase in development of acute respiratory distress syndrome following fire smoke inhalation.

Simon S Wong1, Nina N Sun, R Clark Lantz, Mark L Witten.   

Abstract

To characterize the tachykininergic effects in fire smoke (FS)-induced acute respiratory distress syndrome (ARDS), we designed a series of studies in rats. Initially, 20 min of FS inhalation induced a significant increase of substance P (SP) in bronchoalveolar lavage fluid (BALF) at 1 h and persisted for 24 h after insult. Conversely, FS disrupted 51.4, 55.6, 46.3, and 43.0% enzymatic activity of neutral endopeptidase (NEP, a primary hydrolyzing enzyme for SP) 1, 6, 12, and 24 h after insult, respectively. Immunolabeling density of NEP in the airway epithelium largely disappeared 1 h after insult due to acute cell damage and shedding. These changes were also accompanied by extensive influx of albumin and granulocytes/lymphocytes in BALF. Furthermore, levels of BALF SP and tissue NEP activity dose dependently increased and decreased, respectively, following 0, low (10 min), and high (20 min) levels of FS inhalation. However, neither the time-course nor the dose-response study observed a significant change in the highest affinity neurokinin-1 receptor (NK-1R) for SP. Finally, treatment (10 mg/kg im) with SR-140333B, an NK-1R antagonist, significantly prevented 20-min FS-induced hypoxemia and pulmonary edema 24 h after insult. Further examination indicated that SR-140333B (1.0 or 10.0 mg/kg im) fully abolished early (1 h) plasma extravasation following FS. Collectively, these findings suggest that a combination of sustained SP and NEP inactivity induces an exaggerated neurogenic inflammation mediated by NK-1R, which may lead to an uncontrolled influx of protein-rich edema fluid and cells into the alveoli as a consequence of increased vascular permeability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194566     DOI: 10.1152/ajplung.00388.2003

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  7 in total

1.  Substance P receptor blockade decreases stretch-induced lung cytokines and lung injury in rats.

Authors:  Fabienne Brégeon; Jean Guillaume Steinberg; Nicolas Andreotti; Jean-Marc Sabatier; Stéphane Delpierre; Sylvie Ravailhe; Yves Jammes
Journal:  J Physiol       Date:  2010-02-22       Impact factor: 5.182

2.  Acute changes in sputum collected from exposed human subjects in mining conditions.

Authors:  Simon S Wong; Nina N Sun; Hugh B Miller; Mark L Witten; Jefferey L Burgess
Journal:  Inhal Toxicol       Date:  2010-05       Impact factor: 2.724

3.  Role of neprilysin in airway inflammation induced by diesel exhaust emissions.

Authors:  Simon S Wong; Nina N Sun; Cynthia D Fastje; Mark L Witten; R Clark Lantz; Bao Lu; Duane L Sherrill; Craig J Gerard; Jefferey L Burgess
Journal:  Res Rep Health Eff Inst       Date:  2011-06

4.  Substance P antagonist CP-96345 blocks lung vascular leakage and inflammation more effectively than its stereoisomer CP-96344 in a mouse model of smoke inhalation and burn injury.

Authors:  Sam Jacob; Donald J Deyo; Robert A Cox; Reuben K Jacob; David N Herndon; Daniel L Traber; Hal K Hawkins
Journal:  Toxicol Mech Methods       Date:  2010-05       Impact factor: 2.987

5.  Role of calcitonin gene-related peptide (CGRP) in ovine burn and smoke inhalation injury.

Authors:  Matthias Lange; Perenlei Enkhbaatar; Daniel L Traber; Robert A Cox; Sam Jacob; Babu P Mathew; Atsumori Hamahata; Lillian D Traber; David N Herndon; Hal K Hawkins
Journal:  J Appl Physiol (1985)       Date:  2009-04-30

6.  Activation of nicotinic cholinergic receptors prevents ventilator-induced lung injury in rats.

Authors:  Fabienne Brégeon; Francois Xeridat; Nicolas Andreotti; Hubert Lepidi; Stéphane Delpierre; Antoine Roch; Sylvie Ravailhe; Yves Jammes; Jean-Guillaume Steinberg
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

7.  Expression of neutral endopeptidase activity during clinical and experimental acute lung injury.

Authors:  Soshi Hashimoto; Fumimasa Amaya; Kentaro Oh-Hashi; Kazutoshi Kiuchi; Satoru Hashimoto
Journal:  Respir Res       Date:  2010-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.